|
1
|
High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv.
|
Tuberculosis (Edinb)
|
2009
|
2.58
|
|
2
|
Antituberculosis activity of the molecular libraries screening center network library.
|
Tuberculosis (Edinb)
|
2009
|
1.94
|
|
3
|
A cell-based luminescence assay is effective for high-throughput screening of potential influenza antivirals.
|
Antiviral Res
|
2006
|
1.50
|
|
4
|
Qualification of the hemagglutination inhibition assay in support of pandemic influenza vaccine licensure.
|
Clin Vaccine Immunol
|
2009
|
1.44
|
|
5
|
High throughput screening of a library based on kinase inhibitor scaffolds against Mycobacterium tuberculosis H37Rv.
|
Tuberculosis (Edinb)
|
2011
|
1.23
|
|
6
|
Development and validation of a high-throughput screen for inhibitors of SARS CoV and its application in screening of a 100,000-compound library.
|
J Biomol Screen
|
2006
|
1.18
|
|
7
|
High-throughput screening of a 100,000-compound library for inhibitors of influenza A virus (H3N2).
|
J Biomol Screen
|
2008
|
1.15
|
|
8
|
Discovery of novel benzoquinazolinones and thiazoloimidazoles, inhibitors of influenza H5N1 and H1N1 viruses, from a cell-based high-throughput screen.
|
J Biomol Screen
|
2010
|
0.97
|
|
9
|
Novel pyridopyrazine and pyrimidothiazine derivatives as FtsZ inhibitors.
|
Bioorg Med Chem
|
2011
|
0.95
|
|
10
|
Adapting Cell-Based Assays to the High Throughput Screening Platform: Problems Encountered and Lessons Learned.
|
JALA Charlottesv Va
|
2008
|
0.94
|
|
11
|
HTS-driven discovery of new chemotypes with West Nile Virus inhibitory activity.
|
Molecules
|
2010
|
0.91
|
|
12
|
High-throughput screening identifies a bisphenol inhibitor of SV40 large T antigen ATPase activity.
|
J Biomol Screen
|
2011
|
0.91
|
|
13
|
Development of (E)-2-((1,4-dimethylpiperazin-2-ylidene)amino)-5-nitro-N-phenylbenzamide, ML336: Novel 2-amidinophenylbenzamides as potent inhibitors of venezuelan equine encephalitis virus.
|
J Med Chem
|
2014
|
0.89
|
|
14
|
Structure-based virtual screening against SARS-3CL(pro) to identify novel non-peptidic hits.
|
Bioorg Med Chem
|
2008
|
0.88
|
|
15
|
A high-throughput screening assay for inhibitors of bacterial motility identifies a novel inhibitor of the Na+-driven flagellar motor and virulence gene expression in Vibrio cholerae.
|
Antimicrob Agents Chemother
|
2011
|
0.87
|
|
16
|
(S)-N-(2,5-Dimethylphenyl)-1-(quinoline-8-ylsulfonyl)pyrrolidine-2-carboxamide as a small molecule inhibitor probe for the study of respiratory syncytial virus infection.
|
J Med Chem
|
2012
|
0.86
|
|
17
|
A cell based high-throughput screening approach for the discovery of new inhibitors of respiratory syncytial virus.
|
Virol J
|
2013
|
0.85
|
|
18
|
Identification of novel small molecule activators of nuclear factor-κB with neuroprotective action via high-throughput screening.
|
J Neurosci Res
|
2011
|
0.83
|
|
19
|
A high-throughput screening strategy to overcome virus instability.
|
Assay Drug Dev Technol
|
2010
|
0.82
|
|
20
|
Primary and secondary drug screening assays for Friedreich ataxia.
|
J Biomol Screen
|
2011
|
0.80
|
|
21
|
High-throughput RNA interference screening: tricks of the trade.
|
J Lab Autom
|
2013
|
0.80
|
|
22
|
A BSL-4 high-throughput screen identifies sulfonamide inhibitors of Nipah virus.
|
Assay Drug Dev Technol
|
2014
|
0.79
|
|
23
|
Screening methods for influenza antiviral drug discovery.
|
Expert Opin Drug Discov
|
2012
|
0.79
|
|
24
|
The NIH's role in accelerating translational sciences.
|
Nat Biotechnol
|
2012
|
0.79
|
|
25
|
Optimization of potent and selective quinazolinediones: inhibitors of respiratory syncytial virus that block RNA-dependent RNA-polymerase complex activity.
|
J Med Chem
|
2014
|
0.79
|
|
26
|
A high-throughput screen for chemical inhibitors of exocytic transport in yeast.
|
Chembiochem
|
2010
|
0.78
|
|
27
|
NIH: translation centre bridges a gap.
|
Nature
|
2011
|
0.75
|
|
28
|
A highly specific cell-based high-throughput screening assay for ligands of cyclic adenosine monophosphate receptor protein in gram-negative bacteria.
|
Assay Drug Dev Technol
|
2013
|
0.75
|
|
29
|
Polymerization of C-terminally truncated Mycobacterium tuberculosis FtsZ is unlikely to be physiologically relevant.
|
Microbiology
|
2004
|
0.75
|
|
30
|
Adapting high-throughput screening methods and assays for biocontainment laboratories.
|
Assay Drug Dev Technol
|
2015
|
0.75
|